ACE2 and asthma: Apart from the impaired IFN response in asthma and COVID-19 patients, another possible factor for developing a severe respiratory SARS-CoV-2 infection is the rapid increase of ACE2 expression in the first hours of SARS-CoV-2 infection, probably leading to an exaggerated replication and a rapid spread (58).